The majority of tumor promoting TRIMs belong to the p53 negative regulatory TRIMs either through an increased polyubiquitination and subsequent proteasomal degradation or, alternatively, by hindering p53 from entering the nucleus and thereby impairing its transcriptional activity. The gene discussed is TP53; the disease is neoplasm.